SUSMED,Inc. (TYO:4263)
977.00
+16.00 (1.66%)
Jan 23, 2026, 3:30 PM JST
SUSMED,Inc. Company Description
SUSMED,Inc. develops and sells therapeutic applications in Japan.
It operates through DTx product business, and DTx platform business segments. The company develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease.
It also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, the company offers medical data analysis and consulting services.
The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
SUSMED,Inc.
| Country | Japan |
| Founded | 2015 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 43 |
| CEO | Taro Ueno |
Contact Details
Address: MFPR Nihonbashi honcho Bldg Tokyo, 103-0023 Japan | |
| Phone | 86 3 6366 7780 |
| Website | susmed.co.jp |
Stock Details
| Ticker Symbol | 4263 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | JPY |
| ISIN Number | JP3319150003 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Taro Ueno | Chief Executive Officer |